Human PBMCs were activated by Dynabeads Human T activator CD3/CD28 for 4 days before the transplantation (activated PBMCs) to amplify the T cell population responsible for cytotoxicity of Tb535H against tumor cells. This evidence concerns the gene CD28 and neoplasm.